OncologyColorectal cancer incidence is low in patients following a colonoscopy
Introduction
Colorectal cancer (CRC) is one of the most frequent cancers worldwide, and the second leading cause of cancer in Luxembourg. Screening and prevention strategies for CRC are major health policy issues.
Evidence that colorectal adenomas progress to adenocarcinomas and that removing adenomatous polyps prevented CRC was provided by the National Polyp Study (NPS) in 1993 [1]. Follow-up intervals after colonoscopic polypectomy were clearly defined for the first time by the same team [2].
A randomized controlled trial of screening colonoscopy, to define the magnitude of CRC incidence and mortality reduction, has never been done due to the estimated length of time, size of the cohort, and cost [3]. Observational studies are one of the tools to gain further insight into the outcomes of screening colonoscopy.
The primary aim of our study was to assess the incidence of CRC during follow-up of patients having undergone total colonoscopy in routine clinical practice.
Section snippets
Methods
In Luxembourg, colonoscopy is recommended for CRC screening in asymptomatic patients starting at age 50 or earlier in patients with a significant family history of adenoma or CRC. Colonoscopy is reimbursed by social security, but there is no organized screening programme.
In this retrospective study, we analysed colonoscopy reports of all patients having undergone total colonoscopy from January 1994 through June 2007. Age range was 18 years and older, with no upper limit of age. Patients with a
Study population
8950 patients were included in our study, 49.4% of whom were female. Mean age was 56.2 years for men and 55.9 years for women (p > 0.05, t-test). Of our study patients, 10.9% were aged 75 years and older. Indications for colonoscopy included symptoms for 43.3%, screening for 30.7% and remained unknown for 26% of the study population. There was a significant difference in age of patients with symptoms (54.8 years) compared to patients coming for screening (57.1 years) (p < 0.001, t-test). Total
Discussion
Colonoscopy is not a perfect screening tool. Potential disadvantages are the inconvenience of bowel preparation, cost, the risks of sedation, perforation, and not identifying neoplasms [4]. In a virtual colonoscopy study, sensitivity of optical colonoscopy for detecting polyps at least 10 mm in diameter was only 87.5% [5]. Rates of new or missed CRC 6–36 months after colonoscopy from 2 to 6% were reported from Canada [6]. Interval cancers after a colonoscopy might result from lesions missed or
Conflicts of interest
None declared.
References (30)
- et al.
High quality colonoscopies must be an integral part of screening and surveillance programs
Gastroenterology
(2006) - et al.
ASGE guideline: colorectal cancer screening and surveillance
Gastrointest Endosc
(2006) - et al.
Rates of new or missed colorectal cancers after colonoscopy and their risk factors: a population-based analysis
Gastroenterology
(2007) - et al.
Colorectal cancers found after a complete colonoscopy
Clin Gastroenterol Hepatol
(2006) - et al.
Colonoscopic screening in average-risk individuals ages 40 to 49 vs 50 to 59 years
Gastroenterology
(2008) - et al.
Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies
Gastroenterology
(1997) - et al.
Colorectal cancer in patients under close colonoscopic surveillance
Gastroenterology
(2005) - et al.
Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial
Gastrointest Endosc
(2005) - et al.
Five-year colon surveillance after screening colonoscopy
Gastroenterology
(2007) - et al.
New occurrence and recurrence of neoplasms within 5 years of a screening colonoscopy
Am J Gastroenterol
(2002)